LOSS OF EFFICACY OF ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS

被引：0
|
作者：
ROSENTHAL, M
机构：
来源：
JOURNAL OF RHEUMATOLOGY | 1980年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [41] Anti-rheumatic drugs are associated with reduction of cardiovascular risk in patients with rheumatoid arthritis.
    van Halm, VP
    Nurmohamed, MT
    Twisk, JW
    Dijkmans, BA
    Voskuyl, AE
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S704 - S704
  • [42] The Effects of Periodontal Treatment on Rheumatoid Arthritis and of Anti-Rheumatic Drugs on Periodontitis: A Systematic Review
    Inchingolo, Francesco
    Inchingolo, Angelo Michele
    Avantario, Pasquale
    Settanni, Vito
    Fatone, Maria Celeste
    Piras, Fabio
    Di Venere, Daniela
    Inchingolo, Alessio Danilo
    Palermo, Andrea
    Dipalma, Gianna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [43] Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld, CHM
    Jahangier, ZN
    Jacobs, JWG
    Blaauw, AAM
    Brus, HLM
    van Albada-Kuipers, GA
    van der Veen, MJ
    Schenk, Y
    ter Borg, EJ
    Bijlsma, JWJ
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S271 - S271
  • [44] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    [J]. SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
  • [45] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
  • [46] Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
    Tawaratsumida H.
    Setoguchi T.
    Arishima Y.
    Ohtsubo H.
    Akimoto M.
    Ishidou Y.
    Nagano S.
    Taketomi E.
    Sunahara N.
    Komiya S.
    [J]. BMC Research Notes, 10 (1)
  • [47] The Role of the Standard Basic Anti-Rheumatic Drugs and the Genetically Engineered Biological Drugs in The Treatment of Rheumatoid Arthritis
    Daria, Gerasimova
    Helen, Gerasimova
    Olga, Pashanova
    Lubov, Kondratyeva
    Tatiana, Panafidina
    Tatiana, Popkova
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S37 - S38
  • [48] A meta-analysis of the efficacy and toxicity of combining disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA).
    Choy, EHS
    Smith, C
    Scott, DL
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S170 - S170
  • [49] ANTI-RHEUMATIC DRUGS
    LITTLER, TR
    [J]. PHARMACOLOGY & THERAPEUTICS, 1981, 15 (01) : 45 - 68
  • [50] PEPTIC LESIONS FROM NON-STEROIDAL ANTI-RHEUMATIC DRUGS IN THE UPPER GASTROINTESTINAL-TRACT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    KAUFMANN, S
    KOHL, R
    EHRENFRIED, J
    BORCHERT, F
    GEORGHIOU, T
    WOHLTMANN, D
    GENTH, E
    HARTL, PW
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 290 - 290
12345